Method for reducing intraocular pressure

Details Method for reducing intraocular pressure Method for reducing intraocular pressure

2006-08-01

2006-08-01

Wilson, James O. (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S046000, C514S047000, C514S049000, C514S050000, C514S051000, C514S912000, C514S913000, C514S762000, C514S763000, C536S025600, C536S026100

Reexamination Certificate

active

07084128

ABSTRACT:
The present invention is directed to a method of reducing intraocular pressure. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a purinerginic receptor ligand, which is a mononucleoside polyphosphate or dinucleoside polyphosphate defined by general Formula I. The method of the present invention is useful in the treatment or prevention of ocular hypertension, such as glaucoma, including primary and secondary glaucoma. The method can be used alone to reduce intraocular pressure. The method can also be used in conjunction with other therapeutic agents or adjunctive therapy commonly used to treat glaucoma to enhance the therapeutic effect of reducing the intraocular pressure.

REFERENCES:
patent: 5219849 (1993-06-01), Lotti et al.
patent: 5545626 (1996-08-01), Stein et al.
patent: 5900407 (1999-05-01), Yerxa et al.
patent: 6319908 (2001-11-01), Yerxa et al.
patent: WO 98/34942 (1998-08-01), None
patent: WO 99/61012 (1999-12-01), None
patent: WO 00/03741 (2000-01-01), None
patent: WO 81/87913 (2001-11-01), None
patent: WO 02/09702 (2002-02-01), None
patent: WO 02/16381 (2002-02-01), None
Peral et al., Investigat. Opthalmol. Vis. Science, vol. 41, S255 (2000).
European Search Report, Jun. 2003.
Crawford, et al., “Agonist-induced Ca2+mobilization in cultured bovine and human corneal endothelial cells,”Current Eye Res., 12(4):303-311 (1993).
Jensen, et al., “ATP Release from the Cornea Following Mild Mechanical Stimulation,” poster presentation at American Academy of Optometry annual meeting, Dec. 1999, Seattle, WA.
Jumblatt, et al., “Regulation of Ocular Mucin Secretion by P2Y2Mucleotide Receptors in Rabbit and Human Conjuinctiva,”Exp. Eye Res. 67(3): 341-6 (1998).
Lee, et al., “Alterations of Intracellular Calcium in Human Non-pigmented Ciliary Epithelial Cells of the eye,”Exp. Eye. Res., 48: 733-743 (1989).
Mitchell, et al., “A release mechanism for stored ATP in ocular ciliary epithelial cells,”Proc. Natl. Acad. Sci. U.S.A., 95: 7174-7178 (1998).
Peral, et al., “Effects of diadenosine polyphosphates on introcular pressure and pupil size in New Zealand rabbits”,Investig. Opthalmol. Vis. Science, 41:S255 (2000).
Pintor, et al., “Effect of ATP and adenine nucleotides on intraocular pressure in New Zealnad rabbits,”Investig. Opthalmol. Vis. Science, 41:S255 (2000).
Shahidullah, et al., “Mobilisation of intracellular calcium by P2Y2recepors in cultured, non-transformed bovine ciliary eptithelial cells,”Curr. Eye Res., 16(10): 1006-1016 (1997).
Taylor,The Pharmacological Basis of Therapeutics, Editors: A.G. Gilman, L.S. Goodman, T.W. Rall, and F. Murad, Macmillan Publishing Co., New York, 7: 123-125 (1985).
Wax and Coca-Prados, “Receptor-Mediated Phosphoinositide Hydrolysis in Human Ocular Ciliary Epithelial Cells,”Investig. Opthalmol. Vis. Science, 30(7): 1675-1679 (1989).
Wax, et al., “Purinergic Receptors in Ocular Ciliary Eithelial Cells,”Exp. Eye Res.57: 89-95 (1993).

Affiliated with

Also associated with

Rating

Method for reducing intraocular pressure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for reducing intraocular pressure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing intraocular pressure will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3621057